These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 5067001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Bumetanide, a new diuretic. A clinical assessment of the diuretic effect in patients with chronic congestive heart failure].
    Sigurd B, Leth A, Steiness E.
    Ugeskr Laeger; 1973 Feb 26; 135(9):461-5. PubMed ID: 4703493
    [No Abstract] [Full Text] [Related]

  • 8. Diuretic activity of 3-N-butylamino-4-phenoxy-5-sulphamyl benzoic acid (bumetanide) in hamster.
    Patel RB, Gandhi TP, Shah GF, Patel VC.
    Indian J Physiol Pharmacol; 1979 Feb 26; 23(3):241-3. PubMed ID: 521132
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Study of the sites and mechanisms of action of bumetanide in man.
    Jayakumar S, Puschett JB.
    J Pharmacol Exp Ther; 1977 Apr 26; 201(1):251-8. PubMed ID: 850144
    [Abstract] [Full Text] [Related]

  • 11. Bumetanide: a new potent diuretic. The effects of a single intravenous dose in patients with congestive heart failure.
    Sigurd B, Hesse B, Valentin N.
    Dan Med Bull; 1974 Apr 26; 21(2):63-7. PubMed ID: 4830521
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proceedings: Species differences in the diuretic activity and metabolism of bumetanide.
    Magnussen MP, Eilertsen E.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Apr 26; 282(Suppl):suppl 282:R61. PubMed ID: 4276610
    [No Abstract] [Full Text] [Related]

  • 15. Changes of glomerular filtration rate and renal plasma flow following intravenous bumetanide in organic heart disease.
    Bollerup AC, Hesse B, Sigurd B.
    Acta Pharmacol Toxicol (Copenh); 1974 May 26; 34(5):305-11. PubMed ID: 4406929
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of mefruside in the water diuretic and hydropenic dog: a comparison with chlorothiazide.
    Wilson CB, Kirkendall WM.
    J Pharmacol Exp Ther; 1970 Jun 26; 173(2):422-9. PubMed ID: 5434024
    [No Abstract] [Full Text] [Related]

  • 18. 2-(Aminomethyl)phenols, a new class of saluretic agents. 1. Effects of nuclear substitution.
    Stokker GE, Deana AA, deSolms SJ, Schultz EM, Smith RL, Cragoe EJ, Baer JE, Ludden CT, Russo HF, Scriabine A, Sweet CS, Watson LS.
    J Med Chem; 1980 Dec 26; 23(12):1414-27. PubMed ID: 7452697
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacological activity of the furfuryl amine salt of 4-chloro-N-(2-furylmethyl)-5-sulfamoyl anthranilic acid].
    Lebedev AA, Mironova LI, Pleshakov MG, Matveeva AK.
    Farmakol Toksikol; 1986 Dec 26; 49(6):58-61. PubMed ID: 3817148
    [Abstract] [Full Text] [Related]

  • 20. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR.
    N Z Med J; 1982 Jan 27; 95(700):44-5. PubMed ID: 7038567
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.